A Comparison of the Expression and Metabolizing Activities of Phase I and II Enzymes in Freshly Isolated Human Lung Parenchymal Cells and Cryopreserved Human Hepatocytes

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Drug Metabolism And Disposition

• Publication date

  2007-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/dmd.107.015966PMID 17627976
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination.

  2006cited by this paper
• Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.

  2006cited by this paper
• Guidance for Industry Drug Interaction Studies — Study Design , Data Analysis , and Implications for Dosing and Labeling DRAFT GUIDANCE

  2006cited by this paper
• IN VITRO METABOLISM OF NAPHTHALENE BY HUMAN LIVER MICROSOMAL CYTOCHROME P450 ENZYMES

  2006cited by this paper
• Xenobiotic-metabolizing enzymes in human lung.

  2006cited by this paper
• Systemic Delivery of Drugs to Humans via Inhalation

  2006cited by this paper
• Inter-species comparison of 7-hydroxycoumarin glucuronidation and sulfation in liver S9 fractions

  2006cited by this paper
• LC/ESI/MS analysis of saturated and unsaturated fatty acids in rat intestinal epithelial cells.

  2006cited by this paper
• Regulation of CYP3A genes in the human respiratory tract.

  2005cited by this paper
• Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach.

  2005cited by this paper
• Isolation and characterization of metabolically competent pulmonary epithelial cells from pig lung tissue

  2005cited by this paper
• Presence of epoxide hydrolase and glutathione S-transferase in human pulmonary alveolar macrophages

  2004cited by this paper
• Understanding the mechanisms of drug-associated interstitial lung disease

  2004cited by this paper
• Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport.

  2004cited by this paper
• Interindividual variability in the rate of salbutamol sulphation in the human lung

  2004influential reference
• Interactions of xenobiotics with the steroid hormone biosynthesis pathway

  2003cited by this paper
• In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5.

  2003cited by this paper
• Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts.

  2003influential reference
• Microsomal N-glucuronidation of nicotine and cotinine: human hepatic interindividual, human intertissue, and interspecies hepatic variation.

  2002cited by this paper
• Contribution of efflux pump activity to the delivery of pulmonary therapeutics.

  2002cited by this paper
• Stereoselective urinary excretion of formoterol and its glucuronide conjugate in human.

  2002cited by this paper
• Presence of phenol UDP-glucuronosyltransferase in bovine alveolar macrophages and bronchial epithelial cells.

  2002cited by this paper
• Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues.

  2002influential reference
• Enantiomeric disposition of inhaled, intravenous and oral racemic-salbutamol in man--no evidence of enantioselective lung metabolism.

  2001cited by this paper
• Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man.

  2001cited by this paper
• Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.

  2001cited by this paper
• Relative Enzymatic Activity, Protein Stability, and Tissue Distribution of Human Steroid-Metabolizing UGT2B Subfamily Members**This work was supported by the Medical Research Council of Canada, the Fonds de la Recherche en Santé du Québec, and Endorecherche.

  2001cited by this paper
• Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects.

  2001cited by this paper
• Comparative kinetics of metabolism of beclomethasone propionate esters in human lung homogenates and plasma.

  2000cited by this paper
• Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction.

  2000cited by this paper
• Stereoselective glucuronidation of formoterol by human liver microsomes.

  2000cited by this paper
• Mass balance and metabolism of [(3)H]Formoterol in healthy men after combined i.v. and oral administration-mimicking inhalation.

  1999cited by this paper
• Determination of the enantiomers of salbutamol and its 4-O-sulphate metabolites in biological matrices by chiral liquid chromatography tandem mass spectrometry.

  1998cited by this paper
• Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.

  1998cited by this paper
• Expression and localization of CYP3A4 and CYP3A5 in human lung.

  1997cited by this paper
• UDP-glucuronyl transferase enzyme family in both human and Balb/c mouse lung.

  1997cited by this paper
• Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.

  1997influential reference
• Reversible formation of fatty acid esters of budesonide, an antiasthma glucocorticoid, in human lung and liver microsomes.

  1997cited by this paper
• Sulfation and glucuronidation of acetaminophen by human hepatocytes cultured on Matrigel and type 1 collagen reproduces conjugation in vivo.

  1995cited by this paper
• Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver.

  1995cited by this paper
• Use of isolated lung cells in pulmonary toxicology.

  1993cited by this paper
• Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues.

  1993cited by this paper
• Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.

  1993influential reference
• Tissue distribution of drug-metabolizing enzymes in humans.

  1988cited by this paper
• Drug metabolism in man and its relationship to that in three rodent species: monooxygenase, epoxide hydrolase, and glutathione S-transferase activities in subcellular fractions of lung and liver.

  1984influential reference
• Cleavage of the ARG 1 -PRO 2 Bond of Bradykinin by a Human Lung Peptidase: Isolation, Characterization, and Inhibition by Several β-Lactam Antibiotics 1

  1984cited by this paper
• ReviewPure appl. Chem: Rinehart, K. L., et al. Marine natural products as sources of antiviral, antimicrobial, and antineoplastic Agents. 53, 795 (1981). (K. L. Rinehart, University of Illinois, Urbana, IL 61801, U.S.A.)

  1983cited by this paper
• Glucuronide synthesis in the isolated perfused rat lung.

  1976cited by this paper

• Recent strategies for enhanced delivery of mRNA to the lungs.

  2025cites this paper
• Formulation strategies, preparation methods, and devices for pulmonary delivery of biologics.

  2024cites this paper
• Opportunities and challenges for human microphysiological systems in drug development.

  2024cites this paper
• Intranasal Administration of Bedaquiline-Loaded Fucosylated Liposomes Provides Anti-Tubercular Activity while Reducing the Potential for Systemic Side Effects

  2024cites this paper
• Insights into Inhalation Drug Disposition: The Roles of Pulmonary Drug-Metabolizing Enzymes and Transporters

  2024cites this paper
• Pulmonary Delivery for miRs: Present and Future Potential

  2023cites this paper
• Achieving a Deeper Understanding of Drug Metabolism and Responses Using Single-Cell Technologies

  2023cites this paper
• Metabolism Study of Anamorelin, a GHSR1a Receptor Agonist Potentially Misused in Sport, with Human Hepatocytes and LC-HRMS/MS

  2023cites this paper
• Recent developments in dry powder inhalation (DPI) formulations for lung-targeted drug delivery

  2023cites this paper
• Involvement of esterases in the pulmonary metabolism of beclomethasone dipropionate and the potential influence of cannabis use.

  2022cites this paper
• Alternative Methods for Pulmonary-Administered Drugs Metabolism: a Breath of Change.

  2022cites this paper
• Advances in the design of new types of inhaled medicines.

  2022cites this paper
• In vitro airway models from mice, rhesus macaques, and humans maintain species differences in xenobiotic metabolism and cellular responses to naphthalene.

  2022cites this paper
• Generation of Human Pluripotent Stem Cell‐Derived Polarized Hepatocytes

  2022cites this paper
• Predicting Regional Respiratory Tissue and Systemic Concentrations of Orally Inhaled Drugs through a Novel PBPK Model

  2022cites this paper
• Localized delivery of nanomedicine and antibodies for combating COVID-19

  2022cites this paper
• The pulmonary route as a way to drug repositioning in COVID-19 therapy

  2021cites this paper
• A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market

  2021cites this paper
• Dry Powder Pharmaceutical Biologics for Inhalation Therapy.

  2021cites this paper
• Cell-Specific Drug Targeting in the Lung.

  2021cites this paper
• Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells

  2021cites this paper
• Drug metabolism in the lungs: opportunities for optimising inhaled medicines

  2021influential citation
• Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases.

  2020cites this paper
• Drug Interactions for Low-Dose Inhaled Nemiralisib: A Case Study Integrating Modeling, In Vitro, and Clinical Investigations

  2020cites this paper
• Pulmonary Metabolism of Substrates for Key Drug-Metabolizing Enzymes by Human Alveolar Type II Cells, Human and Rat Lung Microsomes, and the Isolated Perfused Rat Lung Model

  2020cites this paper
• Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation.

  2020cites this paper
• Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)-Based Proteomics of Drug-Metabolizing Enzymes and Transporters

  2020cites this paper
• LPS-induced inflammation delays the transportation of ASP+ due to down-regulation of OCTN1/2 in alveolar epithelial cells

  2020cites this paper
• The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications.

  2019cites this paper
• Insight into pulmonary drug delivery: Mechanism of drug deposition to device characterization and regulatory requirements.

  2019cites this paper
• Comparison of Rat and Human Pulmonary Metabolism Using Precision-cut Lung Slices (PCLS).

  2019cites this paper
• Xenobiotica-metabolizing enzymes in the lung of experimental animals, man and in human lung models

  2019cites this paper
• Inhalable locust bean gum microparticles co-associating isoniazid and rifabutin: therapeutic assessment in a murine model of tuberculosis infection.

  2019cites this paper
• Nrf2-activated expression of sulfiredoxin contributes to urethane-induced lung tumorigenesis.

  2018cites this paper
• Evaluation of Drug-Induced Liver Injuries (DILI) with Human Hepatocytes: Scientific Rationale and Experimental Approaches

  2018cites this paper
• 15.05 – Alveolar Epithelium in Lung Toxicology

  2018cites this paper
• Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs.

  2017cites this paper
• A review of co-milling techniques for the production of high dose dry powder inhaler formulation

  2017cites this paper
• Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening

  2017cites this paper
• Assessing the viability of long-acting β2-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspective

  2017cites this paper
• Bronchopulmonary pharmacokinetics of (R)‐salbutamol and (S)‐salbutamol enantiomers in pulmonary epithelial lining fluid and lung tissue of horses

  2017cites this paper
• Do We Need to Study Metabolism and Distribution in the Eye: Why, When, and Are We There Yet?

  2017cites this paper
• Aerosolizable modified‐release particles of montelukast improve retention and availability of the drug in the lungs

  2017cites this paper
• EXPLORATION OF THE SRX-PRX AXIS AS A SMALL-MOLECULE TARGET

  2016cites this paper
• Modeling the personalized variations in liver disease due to α1-antitrypsin deficiency using induced pluripotent stem cell-derived hepatocyte-like cells

  2015cites this paper
• “Target-Site” Drug Metabolism and Transport

  2015influential citation
• Chapter 2 Pulmonary Drug Metabolism , Clearance , and Absorption

  2015cites this paper
• Lung Anatomy and Physiology and Their Implications for Pulmonary Drug Delivery

  2015cites this paper
• Targeting Inhaled Therapy beyond the Lungs

  2014cites this paper
• Gene expression analysis of membrane transporters and drug-metabolizing enzymes in the lung of healthy and COPD subjects

  2014cites this paper
• Development of 3D Dynamic Flow Model of Human Liver and Its Application to Prediction of Metabolic Clearance of 7-Ethoxycoumarin

  2014influential citation
• Pulmonary Metabolism of Resveratrol: In Vitro and In Vivo Evidence

  2013cites this paper
• Regulatory toxicology considerations for the development of inhaled pharmaceuticals

  2013cites this paper
• Mechanisms of absorption and elimination of drugs administered by inhalation.

  2013cites this paper
• Pharmacokinetic Mechanism Involved in the Prolonged High Retention of Laninamivir in Mouse Respiratory Tissues after Intranasal Administration of its Prodrug Laninamivir Octanoate

  2013cites this paper
• Metabolic considerations of drugs in the treatment of allergic diseases

  2013cites this paper
• UDP-glucuronosyltransferases in sickness and health : Studies on bilirubin and steroid glucuronidation

  2013cites this paper
• Polyethylene glycol-drug ester conjugates for prolonged retention of small inhaled drugs in the lung.

  2013cites this paper
• Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control.

  2013cites this paper
• Increasing drug retention in lung tissue through conjugation with polyethylene-glycol

  2013cites this paper
• Drug Delivery: Pulmonary Delivery

  2013cites this paper
• DMD051326 1163..1169

  2013cites this paper
• Role of the Uridine Diphosphate Glucuronosyltransferase 2a Family in Tobacco Carcinogen Metabolism

  2012cites this paper
• Regulation of Drug Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

  2012cites this paper
• Detoxication of Benzo[a]pyrene-7,8-dione by Sulfotransferases (SULTs) in Human Lung Cells*

  2012cites this paper
• DMD048280 180..187

  2012cites this paper
• UDP‐Glucuronosyltransferases: Pharmacogenetics, Functional Characterization, and Clinical Relevance

  2012cites this paper
• Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues

  2012cites this paper
• Pulmonary Drug Metabolism, Clearance, and Absorption

  2011cites this paper
• Effects of BSA on in vitro Glucuronidation studies using human microsomes and recombinant enzymes

  2011cites this paper
• Integrated in vitro experimental modelling of inhaled drug delivery: deposition, dissolution and absorption

  2011cites this paper
• Light-dark oscillations in the lung transcriptome: implications for lung homeostasis, repair, metabolism, disease, and drug action.

  2011cites this paper
• Alveolar Epithelium in Lung Toxicology

  2010cites this paper
• Development of [111In]-DTPA-buserelin for GnRH receptor studies

  2010cites this paper
• Stereoselectivity of the Human UDP-glucuronosyltransferases : Studies on Androgens and Propranolol Glucuronidation

  2010influential citation
• Dynamic cytotoxic response to microcystins using microelectronic sensor arrays.

  2009cites this paper
• In Vitro Glucuronidation of Fenofibric Acid by Human UDP-Glucuronosyltransferases and Liver Microsomes

  2009cites this paper
• In vitro glucuronidation of fenofibric acid by human UGTs and liver microsomes.

  2009cites this paper
• Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3

  2009cites this paper
• Formed and preformed metabolites: facts and comparisons

  2008cites this paper
• Critical appraisal of the expression of cytochrome P450 enzymes in human lung and evaluation of the possibility that such expression provides evidence of potential styrene tumorigenicity in humans.

  2008cites this paper
• Biological evaluation of ( 18 F)-nifedipine as a novel PET tracer for L-type calcium channel imaging

  2008cites this paper
• Final report on carcinogens background document for styrene.

  2008cites this paper
• Changes in gene expression induced by polycyclic aromatic hydrocarbons in the human cell lines HepG2 and A549.

  2008cites this paper